Bookshelf ID: NBK570371PMID: 34003615
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
This publication is provided for historical reference only and the information may be out of date.
Coronavirus Disease 2019 (COVID-19) Treatment Guidelines
Bethesda (MD): National Institutes of Health (US); 2021 Apr 21-2024 Feb 29.
The Coronavirus Disease 2019 (COVID-19) Treatment Guidelines is published in an electronic format that can be updated in step with the rapid pace and growing volume of information regarding the treatment of COVID-19.
The COVID-19 Treatment Guidelines Panel (the Panel) is committed to updating this document to ensure that health care providers, patients, and policy experts have the most recent information regarding the optimal management of COVID-19 (see the Panel Roster for a list of Panel members).
New Guidelines sections and recommendations and updates to existing Guidelines sections are developed by working groups of Panel members. All recommendations included in the Guidelines are endorsed by a majority of Panel members (see the Introduction for additional details on the Guidelines development process).
NOTE
This title is currently only available in Bookshelf in PDF format (6.0M). The full-text online version of this publication is forthcoming.
Last Update: February 29, 2024.
- The International Liaison Committee on Resuscitation (ILCOR) consensus on science with treatment recommendations for pediatric and neonatal patients: pediatric basic and advanced life support.[Pediatrics. 2006]The International Liaison Committee on Resuscitation (ILCOR) consensus on science with treatment recommendations for pediatric and neonatal patients: pediatric basic and advanced life support.International Liaison Committee on Resuscitation. Pediatrics. 2006 May; 117(5):e955-77. Epub 2006 Apr 17.
- Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19.[Ann Intern Med. 2021]Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19.Kuriakose S, Singh K, Pau AK, Daar E, Gandhi R, Tebas P, Evans L, Gulick RM, Lane HC, Masur H, et al. Ann Intern Med. 2021 Aug; 174(8):1151-1158. Epub 2021 Jun 15.
- Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update.[Crit Care Med. 2021]Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update.Alhazzani W, Evans L, Alshamsi F, Møller MH, Ostermann M, Prescott HC, Arabi YM, Loeb M, Ng Gong M, Fan E, et al. Crit Care Med. 2021 Mar 1; 49(3):e219-e234.
- Review Therapeutics and COVID-19: living guideline[ 2022]Review Therapeutics and COVID-19: living guideline. 2022 Jul 14
- Review Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity guidelines.[Expert Rev Neurother. 2013]Review Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity guidelines.Gold R, Oreja-Guevara C. Expert Rev Neurother. 2013 Dec; 13(12 Suppl):55-9.
- Coronavirus Disease 2019 (COVID-19) Treatment GuidelinesCoronavirus Disease 2019 (COVID-19) Treatment Guidelines
Your browsing activity is empty.
Activity recording is turned off.
See more...